| HOME >> MEDICINE >> TECHNOLOGY |
Table 140: EntreMed's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 469
Table 141: Epeius Biotechnologies' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 471
Table 142: Generex's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 473
Table 143: GenOdyssee Pharmaceuticals' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 476
Table 144: GENTICEL's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 478
Table 145: Geron's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 480
Table 146: GlaxoSmithKline's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 484
Table 147: Gliknik's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 488
Table 148: GlobeImmune's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 490
Table 149: Gradalis' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 493
Table 150: Ichor Medical Systems' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 495
Table 151: Idera Pharmaceuticals' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 497
Table 152: ImmunoCellular Therapeutics' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 500
Table 153: ImmunoFrontier's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 502
Table 154: Immunotope's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 506
Table 155: Innate Pharma's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 508
Table 156: Inovio's Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 510
Table 157: Introgen Therapeutics' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 515
Table 158: ISA Pharmaceuticals' Included Cancer Vaccine Drug Pipeline and Competitive Fall-Out 517
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |